Delivery Order SPE2DB22D9239-SPE2DB25FDL36
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,234.25 for Botox 200-unit vials by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a discrete order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $11,564.25 for Botox 100-unit vials by the Defense Logistics Agency's Medical Supply Chain division. The firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,643.30 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Botox 200 unit vials. The award is structured as a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was executed without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $64.7K with an ultimate completion date of September 18, 2025, carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,762.20 by the Defense Logistics Agency for the supply of Botox 200 unit vials. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a direct pharmaceutical supply requirement for Department of Defense healthcare facilities. The award was executed without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL36Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $64,685 by the Defense Logistics Agency on August 26, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order is scheduled for completion by September 17, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the Defense Logistics Agency to provide essential medical supplies and medications to Department of Defense healthcare systems. The company's portfolio demonstrates extensive experience delivering specialty pharmaceutical products, including biologics and branded prescription medications, to military facilities. This delivery order for Botox represents one of numerous pharmaceutical product acquisitions DMS Pharmaceutical Group fulfills for federal healthcare operations, reinforcing the company's role as a preferred vendor for medical supply distribution to the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $64.7k | 8/26/25 |